Work experience

• PostDoctoral position

  Shenzhen institute of advanced technology

  2024.03-Current

  (2 years)

  • Produced and optimized hybrid OMV–liposome adjuvants forming the basis for vaccines projects targeting HPV, Chikungunya, and H5N1. • Led the development of an original patent, including full documentation and successfully submitted applications for both China and International protection. • Skilled in grant writing, with experience in designing and coordinating research projects from conception to implementation, including those with potential for industrial application.
• PostDoctoral position

  university of Trento, Italy.

  2023.06-2024.03

  (10 months)

  Laboratory of synthetic and structural vaccinology (P.I. professor Guido Grandi). • Optimized OMV-based vaccine candidates with a focus on antitumor applications in a translational, industry-oriented environment. • Cooperated with the spin-off company Biomvis and external partners such as Evaxion to advance vaccine development and commercialization. • Contributed to the design, testing, and optimization of vaccine formulations bridging academic research with industrial applications. • Prepared grant proposals and reports; coordinated cross-disciplinary projects. • Supervised and mentored Master’s students in experimental and analytical activities.
• PhD Researcher

  university of Trento, Italy.

  2019.11-2023.05

  (4 years)

  • Managed a multi-year project on OMV-based vaccine platforms in a laboratory with strong industrial orientation. • Conducted vaccine design, immunology studies, and translational research. • Cooperated with biotech companies to test and develop OMV vaccines for infectious disease prevention.
• Post graduated research fellow

  bambino gesu children's hospital in rome

  2017.11-2019.05

  (2 years)

  • Conducted biological, functional, and genetic characterization of mesenchymal stromal cells from pediatric patients with acute myeloid leukemia and neuroblastoma. • Contributed to translational immunology and oncology research. • Cooperated onaregenerative medicine program for pediatric esophageal reconstruction, integrating cell biology with clinical applications. • Worked in a hospital research environment, coordinating with multidisciplinary teams of clinicians, scientists, and technicians.
• Trainee

  Bambino Gesù children’s hospital in Rome

  2016.10-2017.10

  (a year)

  • Conducted biological, functional, and genetic characterization of mesenchymal stromal cells from pediatric patients with acute myeloid leukemia and neuroblastoma. • Contributed to translational immunology and oncology research. • Cooperated onaregenerative medicine program for pediatric esophageal reconstruction, integrating cell biology with clinical applications. • Worked in a hospital research environment, coordinating with multidisciplinary teams of clinicians, scientists, and technicians

Projects

• Development of a new vaccine platform

  developer

  2024.03-Current

  (2 years)

  Development of a new vaccine platform that is low-cost and highly stable, to be sold mainly in developing countries

Educational experience

• University of Trento

  vaccinology and immunology

  2019.11-2023.05

  (4 years)

  • Managed a multi-year project on OMV-based vaccine platforms in a laboratory with strong industrial orientation. • Conducted vaccine design, immunology studies, and translational research. • Cooperated with biotech companies to test and develop OMV vaccines for infectious disease prevention.
• Sapienza university of Rome

  Genetic and molecular biology

  2015.11-2017.11

  (2 years)

  Experimental graduation thesis in Molecular Biology of Stem Cells titled: “Biological, functional and genetic characterization of the Mesenchymal stromal cells derived from the bone marrow of pediatric patients affected by acute myeloid leukemia”.
• Sapienza university of Rome

  Biological sciences

  2011.10-2015.11

  (4 years)

  Thesis in Molecular Genetic: “Mechanisms of genomic instability, complex chromosomal rearrangement and chromothripsis”

Languages